Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation

Fertility and Sterility

Volumn 97, Issue 5, 2012, Pages

  Binder, Helge ^a   Strick, Reiner ^b   Zaherdoust, Olga ^b   Dittrich, Ralf ^b   Hamori, Miklos ^c   Beckmann, Matthias W ^b   Oppelt, Patricia G ^b  

^a Canton Uri   (Switzerland)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Fertility Treatment Practice   (Germany)

Author keywords

antim llerian hormone; assisted reproduction; FSH receptor; FSHR; gene variations; gonadotropin stimulation; infertility; ovarian reserve

Indexed keywords

FOLLITROPIN RECEPTOR; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR;

ARTICLE; BIRTH RATE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE INFERTILITY; GENE FREQUENCY; GENETIC VARIABILITY; HOMOZYGOSITY; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; PREGNANCY RATE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

EID: 84860345793     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.02.012     Document Type: Article

References (58)

1. B.J. Van Voorhis Clinical practice. In vitro fertilization N Engl J Med 356 2007 379 386
2. Hugues JN. Ovarian stimulation for assisted reproductive technologies. In: Vayena E, Rowe PJ, Griffin PD, editors. Current practices and controversies in assisted reproduction: report of a meeting on "Medical, Ethical and Social Aspects of Assisted Reproduction," WHO Headquarters, Geneva, Switzerland, 2001 Sept 17-21. Geneva: World Health Organization, 2002:102-25. Available at: http://whqlibdoc.who.int/hq/2002/9241590300.pdf.
3. M.F. Verberg, M.J. Eijkemans, N.S. Macklon, E.M. Heijnen, E.B. Baart, and F.P. Hohmann The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis Hum Reprod Update 15 2009 5 12
4. J. Galey-Fontaine, I. Cédrin-Durnerin, R. Chaïbi, N. Massin, and J.N. Hugues Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders Reprod Biomed Online 10 2005 94 99 (Pubitemid 40100661)
5. M.C. Yih, S.D. Spandorfer, and Z. Rosenwaks Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Fertil Steril 83 2005 24 29 (Pubitemid 40094776)
6. Practice Committee of the American Society for Reproductive Medicine Aging and infertility in women Fertil Steril 86 5 Suppl 1 2006 S248 S252
7. M.F.G. Verberg, M.J.C. Eijkemans, N.S. Macklon, E.M.E.W. Heijnen, E.B. Baart, and F.P. Hohmann The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis Hum Reprod Update 15 2009 5 12
8. C. Lussiana, B. Guani, C. Mari, G. Restagno, M. Massobrio, and A. Revelli Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene Obstet Gynecol Surv 63 2008 785 795
9. C. Vasseur, P. Rodien, I. Beau, A. Desroches, C. Gérard, and L. de Poncheville A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome N Engl J Med 349 2003 753 759 (Pubitemid 37010779)
10. H. Binder, R. Dittrich, I. Hager, A. Müller, S. Oeser, and M.W. Beckmann Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome Reproduction 135 2008 107 116
11. A. de la Chapelle Disease gene mapping in isolated human populations: the example of Finland J Med Genet 30 1993 857 865
12. K. Aittomäki, J.L. Lucena, P. Pakarinen, P. Sistonen, J. Tapanainen, and J. Gromoll Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure Cell 82 1995 959 968
13. K. Aittomäki, R. Herva, U.H. Stenman, K. Juntunen, P. Ylöstalo, and O. Hovatta Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene J Clin Endocrinol Metab 81 1996 3722 3726 (Pubitemid 26339945)
14. T.E. Vaskivuo, K. Aittomäki, M. Anttonen, A. Ruokonen, R. Herva, and Y. Osawa Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with an inactivating mutation of the FSH receptor Fertil Steril 78 2002 108 113 (Pubitemid 34722679)
15. I. Beau, P. Touraine, G. Meduri, A. Gougeon, A. Desroches, and C. Matuchansky A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor J Clin Invest 102 1998 1352 1359 (Pubitemid 28467563)
16. R.R. Greb, K. Grieshaber, J. Gromoll, B. Sonntag, E. Nieschlag, and L. Kiesel A common single in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle J Clin Endocrinol Metab 90 2005 4866 4872 (Pubitemid 41159384)
17. M. Perez Mayorga, J. Gromoll, H.M. Behre, C. Gassner, E. Nieschlag, and M. Simoni Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype J Clin Endocrinol Metab 85 2000 3365 3369
18. D.H. Barad, A. Weghofer, and N. Gleicher Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function Fertil Steril 91 2009 1553 1555
19. E.A. Knauff, M.J. Eijkemans, C.B. Lambalk, M.J. ten Kate-Booij, A. Hoek, and C.C. Beerendonk Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure J Clin Endocrinol Metab 94 2009 786 792
20. J. Van Disseldorp, C.B. Lambalk, J. Kwee, C.W. Looman, M.J. Eijkemans, and B.C. Fauser Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts Hum Reprod 25 2010 221 227
21. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, and A.C. Artenisio Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update 16 2010 113 130
22. C.H. Wu, Y.C. Chen, H.H. Wu, J.G. Yang, Y.J. Chang, and H.D. Tsai Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients J Assist Reprod Genet 26 2009 383 389
23. J.A. Visser, F.H. de Jong, J.S.E. Laven, and A.P. Themmen Anti-Müllerian hormone: a new marker for ovarian function Reproduction 131 2006 1 9 (Pubitemid 43230697)
24. S.Y. Shin, J.R. Lee, G.W. Noh, H.J. Kim, W.J. Kang, and S.H. Kim Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-1, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status J Korean Med Sci 23 2008 104 110
25. M. Sowers, D. McConnell, K. Gast, H. Zheng, B. Nan, and J.D. McCarthy Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles Fertil Steril 94 2010 1482 1486
26. A. de Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimüllerian hormone serum levels: a putative marker for ovarian aging Fertil Steril 77 2002 357 362 (Pubitemid 34083560)
27. I.A. van Rooij, F.J. Broekmans, G.J. Scheffer, C.W. Looman, J.D. Habbema, and F.H. de Jong Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study Fertil Steril 83 2005 979 987
28. J. van Disseldorp, M.J. Faddy, A.P. Themmen, F.H. de Jong, P.H. Peeters, and Y.T. van der Schouw Relationship of serum antimüllerian hormone concentration to age of menopause J Clin Endocrinol Metab 93 2008 2129 2134 (Pubitemid 351831526)
29. G.S. Conway Clinical manifestations of genetic defects affecting gonadotrophins and their receptors Clin Endocrinol (Oxf) 45 1996 657 663 (Pubitemid 27032310)
30. A. Pellicer, G. Ardiles, F. Neuspiller, J. Remohi, C. Simon, and F. Bonilla-Musoles Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography Fertil Steril 70 1998 671 675 (Pubitemid 28478183)
31. D.J. Hendriks, J. Kwee, B.W. Mol, E.R. te Velde, and F.J. Broekmans Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count Fertil Steril 87 2007 764 775 (Pubitemid 46550395)
32. P.N. Soldevila, O. Carreras, R. Tur, B. Coroleu, and P.N. Barri Sonographic assessment of ovarian reserve. Its correlation with outcome of in vitro fertilization cycles Gynecol Endocrinol 23 2007 206 212 (Pubitemid 46763726)
33. J. Kwee, M.E. Elting, R. Schats, J. McDonnell, and C.B. Lambalk Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization Reprod Biol Endocrinol 5 2007 9
34. X.M. Zhen, J. Qiao, R. Li, L.N. Wang, and P. Liu The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among Chinese couples J Assist Reprod Genet 25 2008 17 22
35. B.C. Tarlatzis, L. Zepiridis, G. Grimbizis, and J. Bontis Clinical management of low ovarian response to stimulation for IVF: a systematic review Hum Reprod Update 9 2003 61 76 (Pubitemid 36305584)
36. V.C. Karande Managing and predicting low response to standard in vitro fertilization therapy: a review of the options Treat Endocrinol 2 2003 257 272 (Pubitemid 36935105)
37. F. de Castro, R. Ruiz, L. Montoro, D. Pérez-Hernández, E. Sánchez-Casas Padilla, and L.M. Real Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone Fertil Steril 80 2003 571 576 (Pubitemid 37102868)
38. C. Daelemans, G. Smits, V. de Maertelaer, S. Costagliola, Y. Englert, and G. Vassart Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism J Clin Endocrinol Metab 89 2004 6310 6315 (Pubitemid 39628451)
39. M.D. Lalioti Impact of follicle stimulating hormone receptor variants in fertility Curr Opin Obstet Gynecol 23 2011 158 167
40. J. Gromoll, M. Simoni, V. Nordhoff, H.M. Behre, C. De Geyter, and E. Nieschlag Functional and clinical consequences of mutations in the FSH receptor Mol Cell Endocrinol 125 1996 177 182 (Pubitemid 27037796)
41. P. Touraine, I. Beau, A. Gougeon, G. Meduri, A. Desroches, and C. Pichard New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype Mol Endocrinol 13 1999 1844 1854 (Pubitemid 30645258)
42. L.A. Allen, J.C. Achermann, P. Pakarinen, T.J. Kotlar, I.T. Huhtaniemi, and J.L. Jameson A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics Hum Reprod 18 2003 251 256 (Pubitemid 36236254)
43. Y. Nakamura, R. Maekawa, Y. Yamagata, I. Tamura, and N. Sugino A novel mutation in exon 8 of the follicle-stimulating hormone receptor in a woman with primary amenorrhea Gynecol Endocrinol 24 2008 708 712
44. E. Doherty, P. Pakarinen, A. Tiitinen, A. Kiilavuori, I. Huhtaniemi, and S. Forrest A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure J Clin Endocrinol Metab 87 2002 1151 1155 (Pubitemid 36121080)
45. G. Meduri, P. Touraine, I. Beau, O. Lahuna, A. Desroches, and M.C. Vacher-Lavenu Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies J Clin Endocrinol Metab 88 2003 3491 3498 (Pubitemid 37034482)
46. D. Loutradis, E. Patsoula, K. Stefanidis, P. Drakakis, G. Antonakis, and R. Bletsa Follicle-stimulating hormone receptor gene mutations are not evident in Greek women with premature ovarian failure and poor responders Gynecol Obstet Invest 61 2006 56 60 (Pubitemid 43087554)
47. M.B. da Fonte Kohek, M.C. Batista, A.J. Russell, K. Vass, L.R. Giacaglia, and B.B. Mendonca No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure Fertil Steril 70 1998 565 567
48. G.J. Prakash, V.V. Kanth, A.N. Shelling, R. Rozati, and M. Sujatha Absence of 566C>T mutation in exon 7 of the FSHR gene in Indian women with premature ovarian failure Int J Gynaecol Obstet 105 2009 265 266
49. K. Takakura, K. Takebayashi, H.Q. Wang, F. Kimura, K. Kasahara, and Y. Noda Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome Fertil Steril 75 2001 207 209 (Pubitemid 32041247)
50. V. Sundblad, V.A. Chiauzzi, M.E. Escobar, L. Dain, and E.H. Charreau Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF) Mol Cell Endocrinol 222 2004 53 59 (Pubitemid 38900815)
51. G.S. Conway, E. Conway, C. Walker, W. Hoppner, J. Gromoll, and M. Simoni Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome Clin Endocrinol (Oxf) 51 1999 97 99 (Pubitemid 29339541)
52. E. de la Chesnaye, P. Canto, A. Ulloa-Aguirre, and J.P. Méndez No evidence of mutations in the follicle-stimulating hormone receptor gene in Mexican women with 46, XX pure gonadal dysgenesis Am J Med Genet 98 2001 125 128 (Pubitemid 32051800)
53. M. Jiang, K. Aittomäki, C. Nilsson, P. Pakarinen, A. Iitiä, and T. Torresani The frequency of an inactivating point mutation (566c→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry J Clin Endocrinol Metab 83 1998 4338 4343 (Pubitemid 29100132)
54. L.C. Layman, S. Amde, D.P. Cohen, M. Jin, and J. Xie The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46, XX ovarian failure Fertil Steril 69 1998 300 302 (Pubitemid 28117110)
55. E.A. Whitney, L.C. Layman, P.J. Chan, A. Lee, D.B. Peak, and P.G. McDonough The follicle-stimulating hormone receptor gene is polymorphic in premature ovarian failure and normal controls Fertil Steril 64 1995 518 524
56. G.S. Nakhuda, M.V. Sauer, J.G. Wang, M. Ferin, and R.A. Lobo Müllerian inhibiting substance is an accurate marker of ovarian response in women of advanced reproductive age undergoing IVF Reprod Biomed Online 14 2007 450 454 (Pubitemid 46584380)
57. C. Gnoth, A.N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt Relevance of anti-Mullerian hormone measurement in a routine IVF program Hum Reprod 23 2008 1359 1365 (Pubitemid 351770586)
58. A. La Marca, S. Giulini, A. Tirelli, E. Bertucci, T. Marsella, and S. Xella Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology Hum Reprod 22 2007 766 767